Common use of Purchase Warrant Clause in Contracts

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of Kingswood Capital Markets, division of Benchmark Investments, Inc. (“Holder”), as registered owner of this Purchase Warrant, Longeveron Inc., a Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from August 11, 2021 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, February 11, 2026 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 106,400 shares of Class A common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. This Purchase Warrant is initially exercisable at $12.00 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean February 11, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-252234) of the Company was declared effective by the Securities and Exchange Commission.

Appears in 2 contracts

Sources: Purchase Warrant Agreement (Longeveron Inc.), Underwriting Agreement (Longeveron Inc.)

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of Kingswood Capital Markets, division of Benchmark Investments, Inc. (“Holder”), as registered owner of this Purchase Warrant, Longeveron Inc.ComSovereign Holding Corp., a Delaware Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from August 1110, 2021 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, February 1110, 2026 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 106,400 [____] shares of Class A common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $12.00 5.3125 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean February 1110, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-252234252780) of the Company was declared effective by the Securities and Exchange Commission.

Appears in 1 contract

Sources: Underwriting Agreement (ComSovereign Holding Corp.)

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of Kingswood Capital Markets, division of Benchmark Investments, Inc. _____________ (“Holder”), as registered owner of this Purchase Warrant, Longeveron to Ampio Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from August 11July 12, 2021 2013 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, February 11July 12, 2026 2017 (the Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 106,400 [ ] [3% of shares sold in offering excluding over-allotment] of Class A common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. This Purchase Warrant is initially exercisable at $12.00 4.0625 per ShareShare (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean February 11, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-252234) of the Company was declared effective by the Securities and Exchange Commission.

Appears in 1 contract

Sources: Representative’s Warrant Agreement (Ampio Pharmaceuticals, Inc.)

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of Kingswood Capital Markets, division of Benchmark Investments, Inc. ▇▇▇▇▇ ▇. ▇▇▇▇▇ (“Holder”), as registered owner of this Purchase WarrantWarrant of Stran & Company, Longeveron Inc., a Delaware Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from August 11May 12, 2021 2022 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, February 11November 12, 2026 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 106,400 62,287 shares of Class A common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $12.00 5.1875 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean February 11November 8, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-252234260109) of the Company was declared effective by the Securities and Exchange Commission.

Appears in 1 contract

Sources: Representative’s Warrant Agreement (Stran & Company, Inc.)

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of Kingswood Capital MarketsThe Benchmark Company, division of Benchmark Investments, Inc. LLC (“Holder”), as registered owner of this Purchase Warrant, Longeveron Inc.to TFF Pharmaceuticals, Inc. a Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from August 11beginning February 14, 2021 2024 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, February 11August 17, 2026 2028 (the Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 106,400 457,608 shares (the “Shares”) of Class A common stock of the Company, par value $0.001 per share (the “SharesCommon Stock”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $12.00 0.3125 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean February 11, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-252234) of the Company was declared effective by the Securities and Exchange Commission.

Appears in 1 contract

Sources: Purchase Warrant Agreement (TFF Pharmaceuticals, Inc.)

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of Kingswood Craft Capital MarketsManagement, division of Benchmark Investments, Inc. LLC (“Craft” or “Holder”), as registered owner of this Purchase Warrant, Longeveron CaliberCos Inc., a Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from August 11October 14, 2021 2025 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, February 11on April 17, 2026 2030 (the Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 106,400 192,000 shares of Class A common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $12.00 0.4125 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or as may be adjusted from time to time pursuant to the adjusted exercise price, depending on the contextterms hereof. The term “Effective Date” shall mean February 11April 17, 20212025, the date on which the Registration Statement prospectus supplement dated April 17, 2025 to the registration statement on Form S-1 S-3 (File No. 333-252234280243) of the Company (the “Registration Statement”) was declared effective by filed with the Securities and Exchange Commission (the “Commission”), such date being the commencement of sales in the offering pursuant to such prospectus supplement. All capitalized terms used but not defined herein shall have the meanings ascribed to those in the Underwriting Agreement (as defined below).

Appears in 1 contract

Sources: Purchase Warrant Agreement (CaliberCos Inc.)

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by for value received, [•] or on behalf of Kingswood Capital Markets, division of Benchmark Investments, Inc. its assigns (“Holder”), as registered owner of this Purchase Warrant, Longeveron Inc., a Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from August 11[•], 2021 2016 (the “Commencement Date”), and until at or before 5:00 p.m., Eastern time, February 11[•], 2026 2020 (the Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 106,400 [•] shares of Class A common stock of Naked Brand Group, Inc., a Nevada corporation (the Company”), par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. This Purchase Warrant is initially exercisable at $12.00 4.80 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean February 11December 17, 20212015, the date on which the Registration Statement on Form S-1 (File No. 333-252234207110) of the Company (the “Registration Statement”) was declared effective by the U.S. Securities and Exchange Commission (the “Commission”).

Appears in 1 contract

Sources: Underwriting Agreement (Naked Brand Group Inc.)

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of Kingswood Aegis Capital Markets, division of Benchmark Investments, Inc. Corp. (“Holder”), as registered owner of this Purchase Warrant, Longeveron to Alset EHome International Inc., a Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from August 11beginning July 30, 2021 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, February 11July 30, 2026 2023 (the Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 106,400 452,830 shares of Class A common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $12.00 2.65 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean February 11, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-252234) of the Company was declared effective by the Securities and Exchange Commission.

Appears in 1 contract

Sources: Purchase Warrant Agreement (Alset EHome International Inc.)

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of Kingswood Capital MarketsBoustead Securities, division of Benchmark Investments, Inc. LLC (“Holder”), as registered owner of this Purchase Warrant, Longeveron to Hempacco Co., Inc., a Delaware Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from August 11beginning September 1, 2021 2022 (the “Commencement Issue Date”), and at or before 5:00 p.m., Eastern time, February 11August 29, 2026 2027 (the Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 106,400 70,000 shares of Class A common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $12.00 9.00 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean February 11, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-252234) of the Company was declared effective by the Securities and Exchange Commission.

Appears in 1 contract

Sources: Purchase Warrant Agreement (Hempacco Co., Inc.)

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of Kingswood Capital Markets, division of Benchmark Investments, Inc. LLC (“Holder”), as registered owner of this Purchase WarrantWarrant of Stran & Company, Longeveron Inc., a Delaware Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from August 11May 12, 2021 2022 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, February 11November 12, 2026 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 106,400 10,101 shares of Class A common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $12.00 5.1875 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean February 11November 8, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-252234260109) of the Company was declared effective by the Securities and Exchange Commission.

Appears in 1 contract

Sources: Representative’s Warrant Agreement (Stran & Company, Inc.)

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of Kingswood Aegis Capital Markets, division of Benchmark Investments, Inc. Corp. (“Holder”), as registered owner of this Purchase Warrant, Longeveron to AspenBio Pharma, Inc., a Delaware Colorado corporation (the “Company”), Holder is entitled, at any time or from time to time from August 11June 19, 2021 2013 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, February 11June 19, 2026 2017 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 106,400 305,000 shares of Class A common stock of the Company, no par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate the Purchase Warrant. This Purchase Warrant is initially exercisable at $12.00 2.50 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean February 11, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-252234) of the Company was declared effective by the Securities and Exchange Commission.

Appears in 1 contract

Sources: Underwriting Agreement (AspenBio Pharma, Inc.)

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of Kingswood Capital Markets, division of Benchmark Investments, Inc. J▇▇▇ ▇▇ (“Holder”), as registered owner of this Purchase Warrant, Longeveron Inc.to Senmiao Technology Limited, a Delaware Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from August 118, 2021 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, February 118, 2026 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 106,400 380,435 shares of Class A common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $12.00 1.38 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean February 11, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-252234) of the Company was declared effective by the Securities and Exchange Commission.

Appears in 1 contract

Sources: Purchase Warrant Agreement (Senmiao Technology LTD)

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of Kingswood Capital Markets, division of Benchmark Investments, Inc. ▇▇▇▇▇▇ ▇. ▇▇▇▇▇ (“Holder”), as registered owner of this Purchase WarrantWarrant of Stran & Company, Longeveron Inc., a Delaware Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from August 11May 12, 2021 2022 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, February 11November 12, 2026 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 106,400 62,287 shares of Class A common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $12.00 5.1875 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean February 11November 8, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-252234260109) of the Company was declared effective by the Securities and Exchange Commission.

Appears in 1 contract

Sources: Representative’s Warrant Agreement (Stran & Company, Inc.)

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of Kingswood Capital Markets, division of Benchmark Investments, Inc. [●] (“Holder”), as registered owner of this Purchase Warrant, Longeveron to HF Enterprises Inc., a Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from August 11beginning November 27, 2021 2020 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, February 11November 27, 2026 2023 (the Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 106,400 [●] shares of Class A common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $12.00 9.80 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean February 11, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-252234) of the Company was declared effective by the Securities and Exchange Commission.

Appears in 1 contract

Sources: Purchase Warrant Agreement (HF Enterprises Inc.)